Pacific Biosciences
PACB
PACB
262 hedge funds and large institutions have $5.47B invested in Pacific Biosciences in 2021 Q1 according to their latest regulatory filings, with 81 funds opening new positions, 80 increasing their positions, 78 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
3% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 78
5.86% less ownership
Funds ownership: 90.98% → 85.12% (-5.9%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
262
Holding in Top 10
5
Calls
$70.1M
Puts
$29.6M
Top Buyers
| 1 | +$115M | |
| 2 | +$99.1M | |
| 3 | +$51.1M | |
| 4 |
Two Sigma Investments
New York
|
+$47.1M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$46.5M |
Top Sellers
| 1 | -$240M | |
| 2 | -$68.5M | |
| 3 | -$62.3M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$54.5M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$51.6M |